跳转至内容
Merck
CN
  • An MPER antibody neutralizes HIV-1 using germline features shared among donors.

An MPER antibody neutralizes HIV-1 using germline features shared among donors.

Nature communications (2019-11-28)
Lei Zhang, Adriana Irimia, Lingling He, Elise Landais, Kimmo Rantalainen, Daniel P Leaman, Thomas Vollbrecht, Armando Stano, Daniel I Sands, Arthur S Kim, Pascal Poignard, Dennis R Burton, Ben Murrell, Andrew B Ward, Jiang Zhu, Ian A Wilson, Michael B Zwick
摘要

The membrane-proximal external region (MPER) of HIV-1 envelope glycoprotein (Env) can be targeted by neutralizing antibodies of exceptional breadth. MPER antibodies usually have long, hydrophobic CDRH3s, lack activity as inferred germline precursors, are often from the minor IgG3 subclass, and some are polyreactive, such as 4E10. Here we describe an MPER broadly neutralizing antibody from the major IgG1 subclass, PGZL1, which shares germline V/D-region genes with 4E10, has a shorter CDRH3, and is less polyreactive. A recombinant sublineage variant pan-neutralizes a 130-isolate panel at 1.4 μg/ml (IC50). Notably, a germline revertant with mature CDR3s neutralizes 12% of viruses and still binds MPER after DJ reversion. Crystal structures of lipid-bound PGZL1 variants and cryo-EM reconstruction of an Env-PGZL1 complex reveal how these antibodies recognize MPER and viral membrane. Discovery of common genetic and structural elements among MPER antibodies from different patients suggests that such antibodies could be elicited using carefully designed immunogens.

材料
产品编号
品牌
产品描述

Avanti
18:1(Δ9-顺式)PC (DOPC), Avanti Research - A Croda Brand
Avanti
18:1 (Δ9-Cis) PC (DOPC), Avanti Research - A Croda Brand
Avanti
18:1 PS (DOPS), Avanti Research - A Croda Brand
Avanti
18:1 PS (DOPS), Avanti Research - A Croda Brand